2024 Conference Archive: Speakers

Blythe Adamson

Head Outcomes Research & Evidence Generation, International / Health & Chair of the Board
Flatiron / GetReal Institute

Alison Cave

Chief Safety Officer
Medicines and Healthcare products Regulatory Agency (MHRA)

Stephen Duffield

Associate Director for RWE methods
The National Institute for Health and Care Excellence (NICE)

Wim Goettsch

Professor HTA of Pharmaceuticals, WHO Collaborating Centre for Pharmaceutical Policy and Regulation; Division of Pharmacoepidemiology & Clinical Pharmacology
Utrecht University

Manuel Gomes

Professor of Health Economics
UCL

Marcus Guardian

Partner
Dierks+Company
Former EUnetHTA

Iñaki Gutiérrez-Ibarluzea

Head of Knowledge Management and Evaluation
Basque Foundation for Health Innovation and Research (BIOEF)

Shahid Hanif

Managing Director
GetReal Institute

Niklas Hedberg

Chief Pharmacist
TLV

Inka Heikkinen

Director Global Regulatory Policy
MSD / EFPIA

Farah Husein

Director, Science and Methods
Canada’s Drug Agency

Irene Nunes

Senior Vice-President, Global Head of Regulatory Affairs
Genmab

Katrien Oude Rengerink

Methodology Assessor
CBG-MEB

Guillermo Pérez García

HTA Analyst
HTA Unit, Institute for Health Sciences of Aragon (IACS)

Elena Petelos

Public Health Specialist & HTA Expert
University of Crete/Maastricht, EUPHA, HTAi RWE & AI IGC

Juan Carlos Rejón Parrilla

HTA Researcher
Andalusian Health Technology Assessment Unit (AETSA)

Donna Rivera

Associate Director of Pharmacoepidemiology | RWD & RWE
FDA Oncology Center of Excellence

Bettina Ryll

Founder
Melanoma Patient Network Europe

Delphine Saragoussi

Executive Director, Epidemiology & Scientific Affairs
Evidera / ISPE RWE Collaborative SIG

Anja Schiel

Statistician & Methodologist
The Norwegian Medicines Agency (NOMA)

Álmath Spooner

Head of Europe Regulatory Policy
AbbVie

Miriam Sturkenboom

President
VACE4EU

Per-Olof Thuresson

Access Real-World Evidence Chapter Lead
Roche

Anke van Engen

Managing Principal, Value and Payer Evidence
IQVIA

Patrice Verpillat

Head Of The Real World Evidence (RWE) Workstream
European Medicines Agency

Elizabeth Vroom

Chair
World Duchenne Organisation

Silvia Moler Zapata

HTA Analyst
HTA Unit, Institute for Health Sciences of Aragon (IACS)

Scroll to Top